This provider's $8.8M in total Medicare payments ranks in the 99th percentile of Pain Management providers nationally.
Medicare payments to this provider grew 7988% from 2014 to 2023.
76% of their billing comes from a single procedure code (Q4217 — Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 6409% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $144.57 | $35.45 | 4.08x | $109.12 | $55.8K | 1.6K | 12 |
| 2015 | $81.15 | $26.85 | 3.02x | $54.30 | $271.9K | 10.1K | 29 |
| 2016 | $93.96 | $29.72 | 3.16x | $64.24 | $486.3K | 16.4K | 29 |
| 2017 | $141.85 | $44.00 | 3.22x | $97.85 | $358.3K | 8.1K | 26 |
| 2018 | $54.32 | $15.22 | 3.57x | $39.10 | $300.3K | 19.7K | 19 |
| 2019 | $100.50 | $32.88 | 3.06x | $67.62 | $8.4K | 254 | 6 |
| 2020 | $66.72 | $28.74 | 2.32x | $37.98 | $543.6K | 18.9K | 10 |
| 2021 | $49.80 | $19.80 | 2.52x | $30.00 | $436.8K | 22.1K | 15 |
| 2022 | $478.41 | $270.36 | 1.77x | $208.05 | $1.8M | 6.7K | 6 |
| 2023 | $1.1K | $841.55 | 1.36x | $300.44 | $4.5M | 5.4K | 2 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| Q4217 | Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter | 9.8K | $6.2M | $639.50 | 1.46x |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 29.4K | $396.9K | $13.49 | 1.86x |
| Q4174 | Palingen or promatrx, 0.36 mg per 0.25 cc | 984 | $302.8K | $307.75 | 2.50x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 3.5K | $250.2K | $71.16 | 3.07x |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | 349 | $102.9K | $294.80 | 2.77x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 2.1K | $101.9K | $47.62 | 3.18x |
| 77002 | Fluoroscopic guidance for insertion of needle | 1.2K | $94.5K | $80.05 | 2.67x |
| 64636 | Destruction of lower or sacral spinal facet joint nerves with imaging guidance | 685 | $85.0K | $124.02 | 2.84x |
| 20551 | Injections of tendon attachment to bone | 3.1K | $77.6K | $25.10 | 4.57x |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | 437 | $71.7K | $163.98 | 4.76x |
| 20610 | Aspiration and/or injection of fluid from large joint | 1.5K | $65.7K | $45.24 | 2.86x |
| G0480 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 726 | $65.1K | $89.65 | 2.41x |
| G0482 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 325 | $54.9K | $168.87 | 2.66x |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 16.8K | $50.3K | $2.99 | 3.34x |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance | 427 | $43.2K | $101.07 | 4.30x |
| G6056 | Opiate(s), drug and metabolites, each procedure | 1.6K | $39.2K | $25.04 | 4.23x |
| 64495 | Injections of lower or sacral spine facet joint using imaging guidance | 382 | $38.9K | $101.81 | 4.40x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 480 | $36.5K | $76.11 | 2.81x |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | 215 | $36.1K | $167.94 | 3.33x |
| J1955 | Injection, levocarnitine, per 1 gm | 1.7K | $28.2K | $16.76 | 1.49x |
This provider submits charges 1.88 times higher than what Medicare actually pays.
A markup ratio of 1.88x means for every $100 Medicare pays, this provider initially charges $188. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data